FDA: Sex Change Pharmaceuticals Cause BLINDNESS in Children

The FDA has warned that Big Pharma drugs given to children to alter their gender may cause blindness and other dangerous side effects.

The U.S. Food and Drug Administration (FDA) just issued a warning about how puberty-blocking drugs is causing a blindness epidemic in trans kids.

Naturalnews.com reports: The new label applies to gonadotropin-releasing hormone (GnRH) agonists, which in children are linked to severe headaches, pressure buildup around the brain, and vision alteration or loss.

Children who take GnRH agonists in order to become their “true selves” risk developing pseudotumor cerebri, also known as idiopathic intracranial hypertension. It involves fluid building up around the brain and spinal cord for no apparent reason, causing high pressure that can damage the brain and the nerve in the back of the eye, known as the optic nerve.

“The new warning includes recommendations to monitor patients taking GnRH agonists for signs and symptoms of pseudotumor cerebri, including headache, papilledema, blurred or loss of vision, diplopia, pain behind the eye or pain with eye movement, tinnitus, dizziness and nausea,” reads an FDA announcement.

GnRH agonists are only approved by the FDA to treat central precocious puberty, a condition in which children experience premature puberty. For girls, this is before the age of eight, and for boys before the age of nine.

In today’s ultra-perverted era of transgender mutilation, a growing number of normal children without this condition are being prescribed GnRH as a way to become “trans” since the drugs stop the body’s production of estrogen and progesterone.

GnRH agonists can also be used to treat other conditions such as endometriosis, uterine fibroids, and infertility – but they were never approved as a way to corral children into the Cult of LGBT.

Any such use of these drugs for trans purposes represents off-label use, which is questionable at best and, in some cases, illegal. Children under the age of 18 can take them with parental consent, but the FDA does not officially approve the drugs for this use.

“GnRH agonists products include Lupron Depot-Ped (leuprolide acetate), Fensolvi (leuprolide acetate), Synarel (nafarelin), Supprelin LA (histrelin), and Triptodur (triptorelin),” one report explains.